179 related articles for article (PubMed ID: 1902161)
21. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy.
Dillon PW; Fox PS; Berg CJ; Cardella JF; Krummel TM
J Pediatr Surg; 1993 Oct; 28(10):1264-8; discussion 1268-9. PubMed ID: 8263684
[TBL] [Abstract][Full Text] [Related]
22. Fibrinolytic (rt-PA) therapy for superior vena cava thrombosis in a multiple trauma patient.
Imberti R; Albertario F; Bellinzona G; Dionigi RV; Preseglio I; Mapelli A
Acta Anaesthesiol Belg; 1991; 42(4):233-6. PubMed ID: 1796733
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of superior vena cava syndrome with urokinase in an infant.
Wilson CM; Merritt RJ; Thomas DW
JPEN J Parenter Enteral Nutr; 1988; 12(1):81-3. PubMed ID: 3125362
[TBL] [Abstract][Full Text] [Related]
24. Thrombosis of superior vena cava during total parenteral nutrition, managed successfully with low dose streptokinase.
Halevy A; Leonov Y; Lewinsohn G; Witz E; Orda R
Intensive Care Med; 1988; 14(1):72-3. PubMed ID: 3125237
[TBL] [Abstract][Full Text] [Related]
25. Urokinase. A cost-effective alternative treatment of superior vena cava thrombosis and obstruction.
Meister FL; McLauglin TF; Tenney RD; Sholkoff SD
Arch Intern Med; 1989 May; 149(5):1209-10. PubMed ID: 2719514
[TBL] [Abstract][Full Text] [Related]
26. [Iatrogenic superior vena cava syndrome. Successful thrombolysis with recombinant tissue plasminogen activator (r-tPA)].
Sternlo JE; Askelöf N
Lakartidningen; 1992 Jan; 89(4):214-5. PubMed ID: 1734155
[No Abstract] [Full Text] [Related]
27. Iatrogenic superior vena cava syndrome treated with streptokinase.
Matthews JA; Blake HA; Hall DJ
Gynecol Oncol; 1987 Jan; 26(1):119-22. PubMed ID: 3792928
[TBL] [Abstract][Full Text] [Related]
28. "The Scalpel or the Needle for Superior Vena Cava syndrome"?
Chandra D; Pothineni NV; Meena N
J Ark Med Soc; 2015 Aug; 112(3):34-5. PubMed ID: 26376553
[TBL] [Abstract][Full Text] [Related]
29. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
Schranz D; Haugwitz D; Zimmer B; Schumacher R
Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
[TBL] [Abstract][Full Text] [Related]
30. Treatment of superior vena cava syndrome with recombinant tissue plasminogen activator in a sickle cell patient undergoing bone marrow transplantation.
Ramdas J; Haymon M; Ward K; Velez M; Yu LC
Pediatr Hematol Oncol; 2001; 18(1):71-7. PubMed ID: 11205844
[TBL] [Abstract][Full Text] [Related]
31. [Superior vena cava and right atrium thrombosis successfully treated with streptokinase].
Baruzzi AC; Katz A; Smith MR; Aun R; Cirenza C; Araujo AL; Knobel E
Arq Bras Cardiol; 1997 Jan; 68(1):35-7. PubMed ID: 9334458
[TBL] [Abstract][Full Text] [Related]
32. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
33. [Vena cava superior syndrome in total parenteral nutrition. Vena cava superior thrombosis caused by a central venous catheter].
Svane S
Tidsskr Nor Laegeforen; 1990 Mar; 110(7):840-2. PubMed ID: 2108513
[TBL] [Abstract][Full Text] [Related]
34. Tunneled central venous catheter complications and the iatrogenic superior vena cava syndrome.
Presant CA
N Y State J Med; 1992 Feb; 92(2):43-4. PubMed ID: 1565309
[No Abstract] [Full Text] [Related]
35. Resolution of superior vena cava obstruction following thrombolytic therapy in a patient with cystic fibrosis and a long-term indwelling catheter.
Peckham DG; Hill J; Manhire AR; Knox AJ
Respir Med; 1994 Sep; 88(8):627-9. PubMed ID: 7991889
[No Abstract] [Full Text] [Related]
36. Superior vena cava syndrome due to central port catheter thrombosis: a real life-threatening condition.
Lianos GD; Hasemaki N; Tzima E; Vangelis G; Tselios A; Mpailis I; Lekkas E
G Chir; 2018; 39(2):101-106. PubMed ID: 29694310
[TBL] [Abstract][Full Text] [Related]
37. [Superior vena cava thrombosis in a patient on hemodialysis].
Saval N; Pou M; López Pedret J; Burrell M; Cases A
Nefrologia; 2004; 24 Suppl 3():35-8. PubMed ID: 15219066
[TBL] [Abstract][Full Text] [Related]
38. Local thrombolytic therapy in superior vena cava syndrome secondary to malignant thymoma: a case report and literature review.
Enders GC; Sodums MT
Cathet Cardiovasc Diagn; 1994 Mar; 31(3):215-8. PubMed ID: 8025939
[TBL] [Abstract][Full Text] [Related]
39. Implanted central venous catheter-related acute superior vena cava syndrome: management by metallic stent and endovascular repositioning of the catheter tip.
Qanadli SD; Mesurolle B; Sissakian JF; Chagnon S; Lacombe P
Eur Radiol; 2000; 10(8):1329-31. PubMed ID: 10939501
[TBL] [Abstract][Full Text] [Related]
40. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.
Atkinson JB; Bagnall HA; Gomperts E
JPEN J Parenter Enteral Nutr; 1990; 14(3):310-1. PubMed ID: 2112648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
